| Literature DB >> 25136617 |
Eduardo H S Ramos1, Marcílio M Moraes2, Laís L de A Nerys1, Silene C Nascimento1, Gardênia C G Militão3, Regina C B Q de Figueiredo4, Cláudio A G da Câmara2, Teresinha Gonçalves Silva1.
Abstract
The essential oils from Mangifera indica var. Rosa and Espada latex were obtained by hydrodistillation and analyzed using GC-FID and GC-MS. Twenty-seven components were identified. The main compound in the essential oil from M. indica var. Espada (EOMiE) was terpinolene (73.6%). The essential oil of M. indica var. Rosa (EOMiR) was characterized by high amounts of β-pinene (40.7%) and terpinolene (28.3%). In the test for leishmanicidal activity against promastigotes forms of L. amazonensis, EOMiR and EOMiE showed IC50 (72 h) of 39.1 and 23.0 μg/mL, respectively. In macrophages, EOMiR and EOMiE showed CC50 of 142.84 and 158.65 μg/mL, respectively. However, both were more specific to the parasite than macrophages, with values of selectivity index of 6.91 for EOMiE and 3.66 for EOMiR. The essential oils were evaluated for their cytotoxicity against the human tumor cells HEp-2, HT-29, NCI-H292, and HL-60. The EOMiR and EOMiE were most effective against the HL-60, with IC50 values of 12.3 and 3.6 μg/mL, respectively. The results demonstrated that the essential oils of M. indica can destroy L. amazonensis and inhibit tumor cell growth. These findings contribute to the knowledge of the Brazilian biodiversity as a source of potential therapeutic agents.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25136617 PMCID: PMC4124710 DOI: 10.1155/2014/734946
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Chemical composition of the essential oils from the latex of two varieties of M. indica var. Rosa and Espada.
| Compounds | RIa | RIb |
|
| Method of identification |
|---|---|---|---|---|---|
| Yield (%) ± SD | 5.6 ± 0.0 | 9.5 ± 0.1 | |||
|
| 930 | 932 | 0.8 ± 0.0 | 11.5 ± 0.1 | RI, MS, CI |
| Camphene | 941 | 946 | 0.3 ± 0.0 | RI, MS, CI | |
| Sabinene | 966 | 969 | 1.9 ± 0.0 | RI, MS | |
|
| 979 | 974 | 1.9 ± 0.0 | 40.7 ± 0.3 | RI, MS, CI |
|
| 997 | 1001 | 0.6 ± 0.0 | RI, MS | |
|
| 1005 | 1008 | 5.7 ± 0.0 | 2.1 ± 0.0 | RI, MS |
|
| 1012 | 1014 | 2.5 ± 0.0 | 1.0 ± 0.0 | RI, MS, CI |
|
| 1018 | 1020 | 0.4 ± 0.0 | 0.3 ± 0.0 | RI, MS, CI |
| Limonene | 1023 | 1024 | 1.4 ± 0.1 | 1.3 ± 0.0 | RI, MS, CI |
| Sylvestrene | 1025 | 1025 | 0.9 ± 0.0 | 0.7 ± 0.0 | RI, MS |
| ( | 1039 | 1044 | 0.6 ± 0.0 | RI, MS | |
|
| 1050 | 1054 | 0.4 ± 0.0 | 0.2 ± 0.0 | RI, MS |
| Terpinolene | 1082 | 1086 | 73.6 ± 0.2 | 28.3 ± 0.1 | RI, MS, CI |
|
| 1180 | 1179 | 0.7 ± 0.0 | 0.3 ± 0.0 | RI, MS |
|
| 1231 | 1235 | 0.3 ± 0.0 | RI, MS | |
|
| 1258 | 1261 | 0.3 ± 0.0 | 0.3 ± 0.0 | RI, MS |
| Isopulegyl acetate | 1271 | 1274 | 0.5 ± 0.0 | 0.1 ± 0.0 | RI, MS |
|
| 1325 | 1328 | 0.1 ± 0.0 | RI, MS | |
|
| 1380 | 1379 | 0.3 ± 0.0 | 0.1 ± 0.0 | RI, MS |
|
| 1400 | 1400 | 0.8 ± 0.0 | 2.9 ± 0.0 | RI, MS |
| Cycloseychellene | 1407 | 1406 | 0.4 ± 0.0 | 0.2 ± 0.0 | RI, MS |
|
| 1435 | 1434 | 0.3 ± 0.0 | 1.5 ± 0.0 | RI, MS, CI |
| Citronellyl propanoate | 1442 | 1444 | 0.1 ± 0.0 | RI, MS | |
|
| 1449 | 1452 | 0.6 ± 0.0 | 0.3 ± 0.0 | RI, MS |
|
| 1472 | 1475 | 3.7 ± 0.2 | 1.3 ± 0.0 | RI, MS, CI |
|
| 1477 | 1478 | 0.4 ± 0.0 | RI, MS | |
|
| 1477 | 1481 | 0.6 ± 0.0 | 0.2 ± 0.0 | RI, MS |
| Monoterpene hydrocarbons | 88.2 ± 0.2 | 88.9 ± 0.4 | |||
| Oxygenated monoterpenes | 1.8 ± 0.1 | 0.8 ± 0.0 | |||
| Sesquiterpene hydrocarbons | 7.1 ± 0.1 | 6.5 ± 0.1 | |||
| Oxygenated sesquiterpenes | 0.1 ± 0.0 | ||||
|
| |||||
| Total | 97.1 ± 0.3 | 96.3 ± 0.5 | |||
aThe retention indices were calculated from the retention times in relation to those of a series of n-alkanes on a 30 m DB-5 capillary column. bLinear retention indices from the literature. RI: retention index; MS: mass spectrum; CI: coinjection with authentic standards.
Figure 1Effects of essential oils on Leishmania amazonensis promastigote forms. Each bar represents the mean ± standard deviation of three independent experiments in triplicate.
Leishmanicidal and cytotoxic effects of essentials oils of M. indica L.
| Treatment | Promastigote IC50 ( | Macrophage CC50 ( | Selectivity index |
|---|---|---|---|
| EOMiR | 39.1 ± 5.6 | 142.8 ± 6.0 | 3.7 |
| EOMiE | 23.0 ± 2.7 | 158.6 ± 2.5 | 6.9 |
The leishmanicidal activity was expressed as the IC50 and CC50 by the linear regression analysis, respectively. Values are mean ± standard deviation from at least three independent experiments in duplicate. Differences were considered significant at a 0.05 level of confidence. SI: CC50 macrophages/IC50 promastigote forms. IC50: concentration inhibiting 50% of the growth of promastigotes; CC50: concentration capable of causing cytotoxic effects of macrophages by 50%.
Cytotoxic activity against human tumor cells of the essential oils from the M. indica var. Rosa and M. indica var. Espada.
| Essential oil |
aIC50 ( | |||
|---|---|---|---|---|
| HT-29 | HEp-2 | NCI-292 | HL-60 | |
| EOMiR | 28.7 | 25.6 | 38.9 | 12.3 |
| 20.3–30.5 | 20.5–31.9 | 31.3–48.4 | 9.5–15.9 | |
|
| ||||
| EOMiE | 9.2 | 6.2 | 14.5 | 3.6 |
| 6.0–14.0 | 4.4–8.6 | 11.4–18.4 | 2.8–4.8 | |
|
| ||||
| Terpinolene | 16.7 | 13.7 | 17.4 | 28.8 |
| 13.0–21.6 | 11.5–16.3 | 14.8–19.6 | 25.6–32.3 | |
|
| ||||
|
| 10.3 | 11.0 | 11.8 | 11.8 |
| 8.7–12.2 | 7.7–15.6 | 9.1–13.5 | 10.0–14.0 | |
|
| ||||
|
| 6.6 | 6.3 | 7.5 | 10.5 |
| 5.8–7.5 | 5.0–8.0 | 5.1–11.0 | 9.1–12.0 | |
|
| ||||
|
| 45.5 | 35.0 | 42.6 | 63.1 |
| 37.6–55.0 | 29.6–41.2 | 35.1–51.9 | 47.4–84.0 | |
|
| ||||
| Terpinolene (74%) + | 22.8 | 26.5 | 29.3 | 27.0 |
| 16.4–31.6 | 22.8–30.8 | 25.8–33.2 | 23.03–31.8 | |
|
| ||||
|
| 22.3 | 30.5 | 40.1 | 7.8 |
| 16.1–31.1 | 25.6–36.4 | 20.6–47.9 | 5.6–10.7 | |
|
| ||||
| Terpinolene (74%) + | 39.4 | 35.0 | 30.4 | |
| 36.0–43.1 | 27.7–44.38 | 21.8–42.2 | ||
|
| ||||
| Doxorubicin | 0.4 | 0.7 | 0.01 | 0.2 |
| 0.3–0.5 | 0.2–1.4 | 0.004–0.3 | 0.01–0.2 | |
aData are presented as IC50 values and 95% confidence intervals obtained by nonlinear regression for all cell lines from two independent experiments. Exposure time: 72 h. HEp-2: larynx carcinoma; NCI-H292: lung mucoepidermoid carcinoma; HT-29: colon adenocarcinoma; and HL-60: promyelocytic leukemia cells. Doxorubicin was used as a positive control. EOMiR: essential oil of M. indica var. Rosa; EOMiE: essential oil of M. indica var. Espada.